News & Events

Consilium Strategic Communications and Westwicke Partners Enter into Joint Venture for Healthcare Focused US IR Advisory
10 April 2017

Consilium Strategic Communications and Westwicke Partners Enter into Joint Venture for Healthcare Focused US IR Advisory

Consilium Strategic Communications and Westwicke Partners Enter into Joint Venture for Healthcare Focused ... Read more...

Consilium Strategic Communications Sponsors Future of Healthcare Investor Forum
26 January 2017

Consilium Strategic Communications Sponsors Future of Healthcare Investor Forum

Consilium Strategic Communications Sponsors Future of Healthcare Investor Forum   ... Read more...

The Economist Events’ War on Cancer 2016
30 November 2016

The Economist Events’ War on Cancer 2016

Press release   The Economist Events’ War on Cancer ... Read more...

Consilium Strategic Communications, Covington and RBC Capital Markets to host the Annual Healthcare Conference 2016
26 October 2016

Consilium Strategic Communications, Covington and RBC Capital Markets to host the Annual Healthcare Conference 2016

LONDON, 26 October 2016 – Consilium Strategic Communications (“Consilium”), a global leader ... Read more...

Consilium Strategic Communications Appoints Cameron Standage and Rosie Phillips as Executive Consultants
11 October 2016

Consilium Strategic Communications Appoints Cameron Standage and Rosie Phillips as Executive Consultants

Consilium Strategic Communications Appoints Cameron Standage and Rosie Phillips as Executive Consultants ... Read more...

Consilium Strategic Communications appointed by Vectura Group plc as international financial PR and IR advisor
15 September 2016

Consilium Strategic Communications appointed by Vectura Group plc as international financial PR and IR advisor

Industry-leading inhaled airways disease focused company selects specialist international healthcare communications advisory ... Read more...

Consilium Strategic Communications advises Cambridge Innovation Capital on its £75m fundraise
22 August 2016

Consilium Strategic Communications advises Cambridge Innovation Capital on its £75m fundraise

Consilium Strategic Communications advises Cambridge Innovation Capital on its £75m fundraise ... Read more...

Melissa Gardiner Joins Consilium Strategic Communications from AstraZeneca
07 June 2016

Melissa Gardiner Joins Consilium Strategic Communications from AstraZeneca

London, 07 June 2016 , Consilium Strategic Communications, a global leader in strategic ... Read more...

Communicating how cutting-edge drug treatments benefit everyone is a tough challenge
26 April 2016

Communicating how cutting-edge drug treatments benefit everyone is a tough challenge

We are in a golden age of understanding the basis of human disease. ... Read more...

Susan Stuart Joins Consilium Strategic Communications
11 April 2016

Susan Stuart Joins Consilium Strategic Communications

Susan Stuart Joins Consilium Strategic Communications   London, 11 ... Read more...

European healthcare pioneers convene at The Economist Events’ Value-based Healthcare in Europe 2016 summit
03 March 2016

European healthcare pioneers convene at The Economist Events’ Value-based Healthcare in Europe 2016 summit

European healthcare pioneers convene at The Economist Events’ Value-based Healthcare in Europe 2016 ... Read more...

Consilium Strategic Communications appointed by Allergy Therapeutics as international financial PR and IR advisor
22 February 2016

Consilium Strategic Communications appointed by Allergy Therapeutics as international financial PR and IR advisor

Consilium Strategic Communications appointed by Allergy Therapeutics as international financial PR and IR ... Read more...

Consilium Strategic Communications Advises Shield Therapeutics plc on its Successful £32.5m Fundraise and forthcoming IPO
15 February 2016

Consilium Strategic Communications Advises Shield Therapeutics plc on its Successful £32.5m Fundraise and forthcoming IPO

Consilium Strategic Communications Advises Shield Therapeutics plc on its Successful £32.5m Fundraise and ... Read more...

The Economist Events’ Value-based Healthcare in Europe 2016
08 February 2016

The Economist Events’ Value-based Healthcare in Europe 2016

Exploring the beginnings of a global paradigm shift toward a value-based model ... Read more...

Consilium Strategic Communications Appointed as Advisor to Sanofi Genzyme
20 January 2016

Consilium Strategic Communications Appointed as Advisor to Sanofi Genzyme

Consilium Strategic Communications Appointed as Advisor to Sanofi Genzyme ... Read more...

Consilium Strategic Communications Advises Newly Launched Dementia Discovery Fund
21 October 2015

Consilium Strategic Communications Advises Newly Launched Dementia Discovery Fund

Global Fund Raises $100 Million to Deliver Novel Treatment Approaches for Dementia ... Read more...

The Economist Events’ War on Cancer 2015
13 October 2015

The Economist Events’ War on Cancer 2015

Fostering dialogue on the human and economic cost of cancer, European policy ... Read more...

Consilium Strategic Communications is Expanding
02 September 2015

Consilium Strategic Communications is Expanding

We’re expanding! Opportunities for a Consultant or Executive Consultant to join the successful ... Read more...

Consilium Strategic Communications Advises Immunocore on its $320 Million (£205 Million) Financing
20 July 2015

Consilium Strategic Communications Advises Immunocore on its $320 Million (£205 Million) Financing

London, 20 July 2015 - Consilium Strategic Communications, a global leader in ... Read more...

Consilium Strategic Communications Appoints Chris Gardner as a Partner
02 July 2015

Consilium Strategic Communications Appoints Chris Gardner as a Partner

London, 2 July 2015 , Consilium Strategic Communications, a global leader in strategic ... Read more...

Consilium Strategic Communications congratulates Convergence Pharmaceuticals on winning Venture Capital-backed Management Team of the Year
26 June 2015

Consilium Strategic Communications congratulates Convergence Pharmaceuticals on winning Venture Capital-backed Management Team of the Year

LONDON, 26 June 2015 – Consilium Strategic Communications (“Consilium”), a global leader in strategic ... Read more...

Consilium Strategic Communications congratulates its clients on their successes at the European Mediscience Awards 2015 in London
12 June 2015

Consilium Strategic Communications congratulates its clients on their successes at the European Mediscience Awards 2015 in London

LONDON, 12 June 2015 – Consilium Strategic Communications (“Consilium”), a global leader in strategic ... Read more...

Consilium Strategic Communications Appoints Hendrik Thys as Executive Consultant
11 June 2015

Consilium Strategic Communications Appoints Hendrik Thys as Executive Consultant

London, 11 June 2015 – Consilium Strategic Communications (“Consilium”), a global leader in strategic ... Read more...

MedDay Pharma appoints Consilium Strategic Communications as its PR agency
06 May 2015

MedDay Pharma appoints Consilium Strategic Communications as its PR agency

LONDON, 06 May 2015 – MedDay Pharma has appointed Consilium Strategic Communications, a global leader ... Read more...

Consilium Strategic Communications Advises Biocartis on its EUR 100 million IPO on Euronext Brussels
30 April 2015

Consilium Strategic Communications Advises Biocartis on its EUR 100 million IPO on Euronext Brussels

London, 30 April 2015 - Consilium Strategic Communications, a global leader in ... Read more...

Consilium Strategic Communications Appoints Chris Welsh as Consultant
07 April 2015

Consilium Strategic Communications Appoints Chris Welsh as Consultant

London, 07 April 2015 – Consilium Strategic Communications, a global leader in healthcare financial ... Read more...

Consilium Strategic Communications’ New Client Wins in Q1 2015
31 March 2015

Consilium Strategic Communications’ New Client Wins in Q1 2015

London, 31 March 2015 : Consilium Strategic Communications, a global leader in healthcare ... Read more...

The Economist Events’ Pharma Summit 2015: The dawn of a new era
23 February 2015

The Economist Events’ Pharma Summit 2015: The dawn of a new era

February 23, 2015: The Pharma Summit, now in its 21st year, is a must-attend ... Read more...

Consilium Strategic Communications Advises on First European Healthcare IPO of 2015
04 February 2015

Consilium Strategic Communications Advises on First European Healthcare IPO of 2015

London, 04 February 2015 – Consilium Strategic Communications, a global leader in ... Read more...

Consilium Strategic Communications’ Review of JP Morgan Healthcare Conference Week in San Francisco January 2015
21 January 2015

Consilium Strategic Communications’ Review of JP Morgan Healthcare Conference Week in San Francisco January 2015

London, 21 January 2015: Consilium Strategic Communications, a global leader in healthcare ... Read more...

Consilium Strategic Communications Appoints Jonathan Birt as a Partner
10 October 2014

Consilium Strategic Communications Appoints Jonathan Birt as a Partner

London, 10 October 2014 – Consilium Strategic Communications, a global leader in healthcare financial ... Read more...

Are you ready for JP Morgan?
12 September 2014

Are you ready for JP Morgan?

Consilium share their top tips on how to prepare for the JP Morgan ... Read more...

Investec and the healthcare sector: Thoughts from Nick Keher
08 September 2014

Investec and the healthcare sector: Thoughts from Nick Keher

Investec and the healthcare sector: Thoughts from Nick Keher 1.If you ... Read more...

An audience with Helsinn’s CEO, Dr. Riccardo Braglia
08 July 2014

An audience with Helsinn’s CEO, Dr. Riccardo Braglia

1.        If you were to be remembered for one achievement in your career, ... Read more...

Preparation, Preparation, Preparation: Communicating in a Crisis
24 April 2014

Preparation, Preparation, Preparation: Communicating in a Crisis

In a recent article for Scrip Intelligence (8 April 14), Consilium Strategic Communications’ co-founding ... Read more...

Consilium Strategic Communications Advises Horizon Discovery Group plc on its AIM Listing
27 March 2014

Consilium Strategic Communications Advises Horizon Discovery Group plc on its AIM Listing

London, 27 March 2014 - Consilium Strategic Communications, a global leader in strategic healthcare ... Read more...

Consilium Strategic Communications Supports The Economist Events’ Pharma Summit 2014
14 March 2014

Consilium Strategic Communications Supports The Economist Events’ Pharma Summit 2014

14 March 2014: Consilium Strategic Communications, as The Economist Events’ 20th Annual Pharma Summit ... Read more...

Consilium Strategic Communications Strengthens Team and Appoints Ex-Journalist Jessica Hodgson as a New Consultant
12 February 2014

Consilium Strategic Communications Strengthens Team and Appoints Ex-Journalist Jessica Hodgson as a New Consultant

London, 12 February 2014 – Consilium Strategic Communications, a global leader in healthcare financial ... Read more...

Consilium Supports BIA Next Generation UK Healthcare Event
23 January 2014

Consilium Supports BIA Next Generation UK Healthcare Event

Six up-and-coming private UK healthcare companies will present at today’s Next Generation UK Healthcare ... Read more...

Consilium Strategic Communications Forms Partnership with US Specialist Healthcare Strategic IR and PR advisor
16 December 2013

Consilium Strategic Communications Forms Partnership with US Specialist Healthcare Strategic IR and PR advisor

London, UK, Singapore and New York, USA – 16 December – Consilium Strategic Communications, ... Read more...

Consilium supports Delete Blood Cancer and Team Margot UK campaign
13 December 2013

Consilium supports Delete Blood Cancer and Team Margot UK campaign

Margot was diagnosed with Leukaemia on 7 October 2013, at just 14 months old. ... Read more...

Consilium Strategic Communications Holds Annual Healthcare Conference
19 November 2013

Consilium Strategic Communications Holds Annual Healthcare Conference

London, 19 November 2013: Consilium Strategic Communications (Consilium), Europe’s only dedicated strategic ... Read more...

CSC Appoints New Partner & Opens First Office in Asia
09 September 2013

CSC Appoints New Partner & Opens First Office in Asia

Appointment of New Partner: Emma Thompson Opening of First Office ... Read more...

Company Launch
25 July 2013

Company Launch

            Europe’s only healthcare specialist financial PR ... Read more...

Kiadis Pharma notice of Annual General Meeting of shareholders
21 April 2017

Kiadis Pharma notice of Annual General Meeting of shareholders

                                                Kiadis Pharma notice of Annual General Meeting of ... Read more...

STAT-Dx Unveils New In-Vitro Diagnostic System DiagCORE®
21 April 2017

STAT-Dx Unveils New In-Vitro Diagnostic System DiagCORE®

STAT-Dx Unveils New In-Vitro Diagnostic System DiagCORE ® ... Read more...

Faron Pharmaceuticals Ltd: Proposed Board Changes
19 April 2017

Faron Pharmaceuticals Ltd: Proposed Board Changes

  Faron Pharmaceuticals Ltd (“Faron” or the “Company”)   ... Read more...

HORIZON DISCOVERY GROUP PLC: Notice of Preliminary Results
19 April 2017

HORIZON DISCOVERY GROUP PLC: Notice of Preliminary Results

  HORIZON DISCOVERY GROUP PLC (“Horizon” or “the Company”) ... Read more...

Mainstay Medical to Present at the MedTech Strategist Innovation Summit: Dublin 2017
19 April 2017

Mainstay Medical to Present at the MedTech Strategist Innovation Summit: Dublin 2017

Mainstay Medical to Present at the MedTech Strategist Innovation Summit: Dublin 2017 ... Read more...

Cellnovo acquires commercial license for Artificial Pancreas Technology from TypeZero Technologies
18 April 2017

Cellnovo acquires commercial license for Artificial Pancreas Technology from TypeZero Technologies

                                                Press Release     Cellnovo ... Read more...

Shield Therapeutics plc - Preliminary Results for the Year Ended 31 December 2016
04 April 2017

Shield Therapeutics plc - Preliminary Results for the Year Ended 31 December 2016

                                                                                                                                          Shield Therapeutics plc (“Shield” or the ... Read more...

Inivata to Present at AACR Annual Meeting 2017
03 April 2017

Inivata to Present at AACR Annual Meeting 2017

  Inivata to Present at AACR Annual Meeting ... Read more...

NetScientific plc: Vortex Biosciences Announces Publications Supportive of its Circulating Tumour Cell Technology
31 March 2017

NetScientific plc: Vortex Biosciences Announces Publications Supportive of its Circulating Tumour Cell Technology

                                                                                                                                                                                ... Read more...

Mainstay Medical to Present at the 24th MedTech Investing Europe Conference
31 March 2017

Mainstay Medical to Present at the 24th MedTech Investing Europe Conference

Mainstay Medical to Present at the 24 th MedTech Investing Europe Conference ... Read more...

Oxford BioMedica notes acceptance by FDA of a Biologics License Application (BLA) filing for CTL019
30 March 2017

Oxford BioMedica notes acceptance by FDA of a Biologics License Application (BLA) filing for CTL019

Oxford BioMedica notes acceptance by FDA of a Biologics License Application (BLA) filing ... Read more...

Cathay International Holdings Limited: Annual Results for the Year Ended 31 December 2016
30 March 2017

Cathay International Holdings Limited: Annual Results for the Year Ended 31 December 2016

Cathay International Holdings Limited (“Cathay” or the “Company” ... Read more...

Faron Pharmaceuticals Ltd - Final Results for the year ended 31 December 2016
29 March 2017

Faron Pharmaceuticals Ltd - Final Results for the year ended 31 December 2016

TURKU – FINLAND, 29 March 2017 Faron Pharmaceuticals Ltd (”Faron”) (LON: FARN), ... Read more...

BICYCLE THERAPEUTICS IS NAMED WINNER OF BUSINESS WEEKLY’S DISRUPTIVE TECHNOLOGY AWARD 2017
29 March 2017

BICYCLE THERAPEUTICS IS NAMED WINNER OF BUSINESS WEEKLY’S DISRUPTIVE TECHNOLOGY AWARD 2017

CAMBRIDGE, U.K. and CAMBRIDGE, MASS. – MARCH 29, 2017 – Bicycle Therapeutics, a biotechnology ... Read more...

Genedrive® HCV Assay submitted for CE IVD Certification
27 March 2017

Genedrive® HCV Assay submitted for CE IVD Certification

genedrive plc (“genedrive” or the “Company”)   ... Read more...

NetScientific plc: Notice of Results
27 March 2017

NetScientific plc: Notice of Results

        (“NetScientific” or ... Read more...

SUMMIT TO EXTEND ONGOING PhaseOut DMD CLINICAL TRIAL OF EZUTROMID IN PATIENTS WITH DMD
27 March 2017

SUMMIT TO EXTEND ONGOING PhaseOut DMD CLINICAL TRIAL OF EZUTROMID IN PATIENTS WITH DMD

Summit Therapeutics plc (‘Summit’, ‘the Company’ or ‘the Group’)   ... Read more...

IBA Reports Full Year Results for 2016
23 March 2017

IBA Reports Full Year Results for 2016

IBA Reports Full Year Results for 2016   Group revenues ... Read more...

Celyad Reports 2016 Financial and Operating Results and Expected Key Milestones for 2017
23 March 2017

Celyad Reports 2016 Financial and Operating Results and Expected Key Milestones for 2017

Celyad Reports 2016 Financial and Operating Results and Expected Key Milestones for 2017 ... Read more...

Mainstay Medical Publishes 2016 Full Year Results and Business Update
23 March 2017

Mainstay Medical Publishes 2016 Full Year Results and Business Update

Mainstay Medical Publishes 2016 Full Year Results and Business Update ... Read more...

Helsinn Advanced Synthesis wins across all categories at 2017 CMO Leadership Awards
23 March 2017

Helsinn Advanced Synthesis wins across all categories at 2017 CMO Leadership Awards

Helsinn Advanced Synthesis wins across all categories at 2017 CMO Leadership Awards ... Read more...

MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
21 March 2017

MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom

NEWS RELEASE                                                                                       REGULATED INFORMATION                                                                                                        ... Read more...

Vectura Group plc: Preliminary Results
21 March 2017

Vectura Group plc: Preliminary Results

Vectura Group plc   Preliminary Results ... Read more...

REDX PHARMA PLC: Final results for the year ended 30 September 2016
21 March 2017

REDX PHARMA PLC: Final results for the year ended 30 September 2016

21 March 2017                                                                                                                                                                                  AIM: REDX ... Read more...

Kiadis Pharma appoints Jan Feijen as Chief Operations Officer
20 March 2017

Kiadis Pharma appoints Jan Feijen as Chief Operations Officer

  Kiadis Pharma appoints Jan Feijen as Chief Operations Officer ... Read more...

Celyad: USPTO rejects new reexamination request against Celyad’s US Patent for Production of Allogeneic TCR-Deficient CAR-T Cells
16 March 2017

Celyad: USPTO rejects new reexamination request against Celyad’s US Patent for Production of Allogeneic TCR-Deficient CAR-T Cells

USPTO rejects new reexamination request against Celyad’s US Patent for Production of Allogeneic TCR-Deficient ... Read more...

Kiadis Pharma to present information on the design of its Phase III trial with ATIR101™ and Phase I/II trial with ATIR201™ at 43rd Annual Meeting of the European Society for Blood
16 March 2017

Kiadis Pharma to present information on the design of its Phase III trial with ATIR101™ and Phase I/II trial with ATIR201™ at 43rd Annual Meeting of the European Society for Blood

                                                                                                                          Kiadis Pharma to ... Read more...

Bone Therapeutics Reports Full Year 2016 Results
16 March 2017

Bone Therapeutics Reports Full Year 2016 Results

  Bone Therapeutics Reports Full Year 2016 Results ... Read more...

Cathay International Holdings Limited: Notice of Annual Results 2016
16 March 2017

Cathay International Holdings Limited: Notice of Annual Results 2016

Cathay International Holdings Limited ("Cathay" or the "Company")   ... Read more...

Mainstay Medical Announces Date for Full Year Results
16 March 2017

Mainstay Medical Announces Date for Full Year Results

Mainstay Medical Announces Date for Full Year Results   ... Read more...

MaxCyte, Inc.- CRISPR THERAPEUTICS/CASEBIA OBTAIN MAXCYTE COMMERCIAL LICENSE
14 March 2017

MaxCyte, Inc.- CRISPR THERAPEUTICS/CASEBIA OBTAIN MAXCYTE COMMERCIAL LICENSE

CRISPR Therapeutics and Casebia obtain commercial rights to MaxCyte’s cell engineering platform to ... Read more...

Horizon Discovery Enters into Agreement with a Leading Global Molecular Diagnostics
14 March 2017

Horizon Discovery Enters into Agreement with a Leading Global Molecular Diagnostics

Agreement to develop and manufacture reference standards to support assay development for ... Read more...

Shield Therapeutics plc - IP Portfolio Update
13 March 2017

Shield Therapeutics plc - IP Portfolio Update

IP Portfolio Update Patent estate fortified for Feraccru ® ... Read more...

Oxford BioMedica: Notice of Preliminary Results
10 March 2017

Oxford BioMedica: Notice of Preliminary Results

Oxford BioMedica: Notice of Preliminary Results Results date: 16 March ... Read more...

Bone Therapeutics to participate in upcoming key investor conferences
10 March 2017

Bone Therapeutics to participate in upcoming key investor conferences

Bone Therapeutics to participate in upcoming key investor conferences Gosselies, ... Read more...

Bone Therapeutics completes recruitment of 16 patients in ALLOB® Phase I/IIA delayed-union study
09 March 2017

Bone Therapeutics completes recruitment of 16 patients in ALLOB® Phase I/IIA delayed-union study

Bone Therapeutics completes recruitment of 16 patients in ALLOB ® Phase I/IIA ... Read more...

Allergy Therapeutics plc: Notice of Interim Results
09 March 2017

Allergy Therapeutics plc: Notice of Interim Results

  Allergy Therapeutics plc ("Allergy Therapeutics" or the ... Read more...

Celyad obtains FDA approval to initiate the NKR-2 CAR T cells THINK trial in the USA
08 March 2017

Celyad obtains FDA approval to initiate the NKR-2 CAR T cells THINK trial in the USA

Celyad obtains FDA approval to initiate the NKR-2 CAR T cells THINK trial in ... Read more...

IBA Notice of Full Year 2016 Results and Conference Call
07 March 2017

IBA Notice of Full Year 2016 Results and Conference Call

IBA Notice of Full Year 2016 Results and Conference Call ... Read more...

Innate Pharma: 2016: OPERATIONAL PROGRESS AND ROBUST FINANCIAL POSITION FOR FURTHER GROWTH
07 March 2017

Innate Pharma: 2016: OPERATIONAL PROGRESS AND ROBUST FINANCIAL POSITION FOR FURTHER GROWTH

2016: operational progress and robust financial position for further growth ... Read more...

Faron Pharmaceuticals Oy: Notice of Full Year Results
07 March 2017

Faron Pharmaceuticals Oy: Notice of Full Year Results

Faron Pharmaceuticals Oy (“Faron” or the “Company”)   ... Read more...

Mainstay Medical to Present at the Canaccord Genuity 2017 Musculoskeletal Conference
07 March 2017

Mainstay Medical to Present at the Canaccord Genuity 2017 Musculoskeletal Conference

Mainstay Medical to Present at the Canaccord Genuity 2017 Musculoskeletal Conference ... Read more...

Bone Therapeutics Strengthens Clinical Development Leadership with Appointment of Dr. Miguel Forte as Chief Medical Officer
06 March 2017

Bone Therapeutics Strengthens Clinical Development Leadership with Appointment of Dr. Miguel Forte as Chief Medical Officer

Bone Therapeutics Strengthens Clinical Development Leadership with Appointment of Dr. Miguel Forte ... Read more...

MedDay Boosts its Research Capabilities with Profilomic Acquisition
06 March 2017

MedDay Boosts its Research Capabilities with Profilomic Acquisition

  MedDay Boosts its Research Capabilities with Profilomic Acquisition ... Read more...

Vectura Group plc - Board Change
06 March 2017

Vectura Group plc - Board Change

Vectura Group plc Board Change   ... Read more...

Bone Therapeutics Notice of Full Year 2016 Results
03 March 2017

Bone Therapeutics Notice of Full Year 2016 Results

Bone Therapeutics Notice of Full Year 2016 Results ... Read more...

Arix Bioscience plc signs strategic agreement with Takeda
02 March 2017

Arix Bioscience plc signs strategic agreement with Takeda

LONDON, 2 MARCH 2017 : Arix Bioscience plc (LSE:ARIX) (“Arix Bioscience” ... Read more...

MITHRA REPORTS 2016 ANNUAL RESULTS
02 March 2017

MITHRA REPORTS 2016 ANNUAL RESULTS

Significant operational progress across our transformational E4 (Estetrol) programs and our complex ... Read more...

MaxCyte to Present Pre-Clinical CARMA Data at AACR Meeting
02 March 2017

MaxCyte to Present Pre-Clinical CARMA Data at AACR Meeting

  In vivo research demonstrates potential of novel, proprietary, ... Read more...

Oxford BioMedica plc - Appointment of New Chief Financial Officer
28 February 2017

Oxford BioMedica plc - Appointment of New Chief Financial Officer

Oxford, UK – 28 February 2017: Oxford BioMedica plc (“Oxford BioMedica” or ... Read more...

Immunocore to Present at the Cowen and Company 37th Annual Healthcare Conference
28 February 2017

Immunocore to Present at the Cowen and Company 37th Annual Healthcare Conference

(Oxford, UK, 28 th February 2017) Immunocore Limited, a world-leading biotechnology company developing ... Read more...

Sphere Medical Holding plc - Results for the year ended 31 December 2016
28 February 2017

Sphere Medical Holding plc - Results for the year ended 31 December 2016

Sphere Medical Holding plc (AIM: SPHR.L), an innovative point-of-care monitoring and diagnostic devices company, ... Read more...

TopiVert commences Phase I study with oral TOP1288 in the treatment of ulcerative colitis
28 February 2017

TopiVert commences Phase I study with oral TOP1288 in the treatment of ulcerative colitis

London, UK, 28 February 2017: TopiVert Pharma Ltd (“TopiVert” or the “Company”),a ... Read more...

SUMMIT THERAPEUTICS RECOGNISES 10TH ANNUAL RARE DISEASE DAY
28 February 2017

SUMMIT THERAPEUTICS RECOGNISES 10TH ANNUAL RARE DISEASE DAY

Summit Therapeutics plc (‘Summit’ or ‘the Company’)   ... Read more...

IBA to install Spain’s first proton therapy center
23 February 2017

IBA to install Spain’s first proton therapy center

IBA to install Spain’s first proton therapy center   ... Read more...

MDxHealth Reports Financial Year 2016 Results
23 February 2017

MDxHealth Reports Financial Year 2016 Results

  NEWS RELEASE                                                                                  REGULATED INFORMATION                                                                                                                             ... Read more...

MDxHealth Announces Agreement with Istituto Diagnostico Varelli for Distribution of SelectMDx™ Throughout Central-South Italy
23 February 2017

MDxHealth Announces Agreement with Istituto Diagnostico Varelli for Distribution of SelectMDx™ Throughout Central-South Italy

  NEWS RELEASE                                                                                        REGULATED INFORMATION INSIDE INFORMATION ... Read more...

IBA Selected to Install New Proton Therapy Center in Charleroi, Belgium
20 February 2017

IBA Selected to Install New Proton Therapy Center in Charleroi, Belgium

IBA Selected to Install New Proton Therapy Center in Charleroi, Belgium   ... Read more...

Faron Pharmaceuticals Oy: First Patient Recruited in Phase II RAAA Study
20 February 2017

Faron Pharmaceuticals Oy: First Patient Recruited in Phase II RAAA Study

  Faron Pharmaceuticals Oy (“Faron” or the “Company”) ... Read more...

Celyad Registers First Hematological Patient in  CAR-T NKR-2 THINK Trial
16 February 2017

Celyad Registers First Hematological Patient in CAR-T NKR-2 THINK Trial

Celyad Registers First Hematological Patient in  CAR-T NKR-2 THINK Trial Opening ... Read more...

Helsinn Provides Grant for ESMO’s Preceptorship Course on Supportive and Palliative Care
15 February 2017

Helsinn Provides Grant for ESMO’s Preceptorship Course on Supportive and Palliative Care

Helsinn Provides Grant for ESMO’s Preceptorship Course on Supportive and Palliative Care ... Read more...

Vectura Group plc: Notice of Preliminary Results
15 February 2017

Vectura Group plc: Notice of Preliminary Results

Vectura Group plc Notice of Preliminary Results ... Read more...

MITHRA GRANTED EUR 1.9 MILLION IN NON-DILUTIVE FUNDING
13 February 2017

MITHRA GRANTED EUR 1.9 MILLION IN NON-DILUTIVE FUNDING

PRESS RELEASE MITHRA granted eur 1.9 million in non-dilutive funding ... Read more...

Helsinn Group Launches “Helsinn Cares” Patient Support Services  in the US
13 February 2017

Helsinn Group Launches “Helsinn Cares” Patient Support Services in the US

Patient Assistance Program and Voucher Program will support both insured and ... Read more...

 Interim Results for the half year ended 30 November 2016
10 February 2017

Interim Results for the half year ended 30 November 2016

This announcement contains inside information.   Oncimmune ... Read more...

MDxHealth Notice of Financial Year 2016 Results
09 February 2017

MDxHealth Notice of Financial Year 2016 Results

NEWS RELEASE                                                                                       REGULATED INFORMATION   MDxHealth ... Read more...

MDxHealth Awarded US Department of Veterans Affairs Contract for ConfirmMDx Testing
08 February 2017

MDxHealth Awarded US Department of Veterans Affairs Contract for ConfirmMDx Testing

    NEWS RELEASE                                                                                       REGULATED INFORMATION ... Read more...

MITHRA COMPLETES RECRUITMENT FOR EUROPEAN PHASE III ESTELLE® STUDY
07 February 2017

MITHRA COMPLETES RECRUITMENT FOR EUROPEAN PHASE III ESTELLE® STUDY

PRESS RELEASE MITHRA COMPLETES RECRUITMENT FOR European phase iii estelle® study ... Read more...

Sphere Medical Holding plc: Notice of Preliminary Results
07 February 2017

Sphere Medical Holding plc: Notice of Preliminary Results

                                                                                                              7 February 2017   Sphere Medical Holding plc ... Read more...

Quanta Appoints World Leading Nephrologist to Medical Advisory Board
06 February 2017

Quanta Appoints World Leading Nephrologist to Medical Advisory Board

Alcester, Warwickshire, UK, 6 February 2017: Quanta Dialysis Technologies Ltd ... Read more...

Allergy Therapeutics plc - Positive Efficacy and Safety Data Shown in Peanut Allergy Vaccine
01 February 2017

Allergy Therapeutics plc - Positive Efficacy and Safety Data Shown in Peanut Allergy Vaccine

1 February 2017 Allergy Therapeutics (AIM:AGY), the fully integrated specialty pharmaceutical company ... Read more...

Mainstay Medical Starts Commercialization of ReActiv8® for the Treatment of Chronic Low Back Pain
01 February 2017

Mainstay Medical Starts Commercialization of ReActiv8® for the Treatment of Chronic Low Back Pain

Dublin – Ireland, 1 February 2017 – Mainstay Medical International plc (“ ... Read more...

MITHRA STRENGTHENS POSITION IN THE BELGIAN CONTRACEPTION MARKET
31 January 2017

MITHRA STRENGTHENS POSITION IN THE BELGIAN CONTRACEPTION MARKET

Mithra builds on leading position in Belgian contraceptive market ... Read more...

Cambridge Innovation Capital appoints Dr Michael Anstey as Investment Director
31 January 2017

Cambridge Innovation Capital appoints Dr Michael Anstey as Investment Director

31 January 2017 Cambridge Innovation Capital plc (CIC), a Cambridge-based investor ... Read more...

Cellnovo: 2016 Full-Year Sales
31 January 2017

Cellnovo: 2016 Full-Year Sales

2016 Full Year Sales show 133% Year-on-Year growth   ... Read more...

genedrive plc - Trading Update
27 January 2017

genedrive plc - Trading Update

genedrive plc, the near patient molecular diagnostics company, today provides a period end update ... Read more...

MITHRA PLANS TO SUBMIT MYRING FOR US AND EU APPROVAL IN Q2 2017
24 January 2017

MITHRA PLANS TO SUBMIT MYRING FOR US AND EU APPROVAL IN Q2 2017

Planned submissions follow successful trials demonstrating bioequivalence to NuvaRing ®   ... Read more...

Horizon Discovery Group plc - Trading Update
24 January 2017

Horizon Discovery Group plc - Trading Update

Group on track to meet market expectations in FY2017 ... Read more...

MaxCyte, Inc. - Trading Update
24 January 2017

MaxCyte, Inc. - Trading Update

Consecutive 30 percent year-on year revenue growth Maryland, USA – ... Read more...

REX initiates RAPPER III: Clinical Trial in Multiple Sclerosis
23 January 2017

REX initiates RAPPER III: Clinical Trial in Multiple Sclerosis

Ethics Committee Approval from NHS’s National Institute for Health Research (NIHR) ... Read more...

Midatech Pharma PLC Trading Update
20 January 2017

Midatech Pharma PLC Trading Update

Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing ... Read more...

MDxHealth Announces Horizon Blue Cross Blue Shield of New Jersey Issues Positive Coverage Policy on ConfirmMDx
18 January 2017

MDxHealth Announces Horizon Blue Cross Blue Shield of New Jersey Issues Positive Coverage Policy on ConfirmMDx

  NEWS RELEASE                                                                                        REGULATED INFORMATION INSIDE INFORMATION ... Read more...

MITHRA ANNOUNCES US PATENT ALLOWANCE FOR THE USE OF ESTETROL AS EMERGENCY CONTRACEPTIVE
18 January 2017

MITHRA ANNOUNCES US PATENT ALLOWANCE FOR THE USE OF ESTETROL AS EMERGENCY CONTRACEPTIVE

PRESS RELEASE MITHRA ANNOUNCES US PATENT ALLOWANCE FOR THE USE OF ESTETROL AS ... Read more...

Bone Therapeutics Provides Business Update for Q4 2016
17 January 2017

Bone Therapeutics Provides Business Update for Q4 2016

Bone Therapeutics Provides Business Update for Q4 2016 ... Read more...

Horizon broadens industry-leading gene editing capabilities through extension of key CRISPR license and grant-funded research
16 January 2017

Horizon broadens industry-leading gene editing capabilities through extension of key CRISPR license and grant-funded research

Horizon broadens industry-leading gene editing capabilities through extension of key CRISPR license and ... Read more...

Mainstay Medical Applies for Approval to Market ReActiv8® in Australia
12 January 2017

Mainstay Medical Applies for Approval to Market ReActiv8® in Australia

Mainstay Medical Applies for Approval to Market ReActiv8 ® in Australia ... Read more...

Celyad Announces USPTO Decision to Uphold US Patent for Production of Allogeneic TCR-Deficient CAR-T Cells
09 January 2017

Celyad Announces USPTO Decision to Uphold US Patent for Production of Allogeneic TCR-Deficient CAR-T Cells

Celyad Announces USPTO Decision to Uphold US Patent for Production of Allogeneic TCR-Deficient CAR-T ... Read more...

MDxHealth Announces Preliminary Update on 2016 Results and Appointment of CFO
09 January 2017

MDxHealth Announces Preliminary Update on 2016 Results and Appointment of CFO

  NEWS RELEASE                                                                                        REGULATED INFORMATION                                                                                                                              INSIDE ... Read more...

C4X Discovery Holdings plc - Full year results for the year ended 31 July 2016
06 January 2017

C4X Discovery Holdings plc - Full year results for the year ended 31 July 2016

This announcement contains inside information   C4X Discovery Holdings ... Read more...

Shield Therapeutics plc: Business Update
06 January 2017

Shield Therapeutics plc: Business Update

Shield Therapeutics plc ("Shield" or the "Group")   ... Read more...

Mainstay Medical to Present at Medtech Showcase 2017
06 January 2017

Mainstay Medical to Present at Medtech Showcase 2017

Mainstay Medical to Present at Medtech Showcase 2017   ... Read more...

Mithra Pharmaceuticals: APPOINTMENT OF CHRISTOPHE MARÉCHAL AS CHIEF FINANCIAL OFFICER
06 January 2017

Mithra Pharmaceuticals: APPOINTMENT OF CHRISTOPHE MARÉCHAL AS CHIEF FINANCIAL OFFICER

PRESS RELEASE Appointment of CHRISTOPHE MarÉchal AS chief financial officer   ... Read more...

Celyad Announces Registration of the first patient in the Belgian THINK trial
05 January 2017

Celyad Announces Registration of the first patient in the Belgian THINK trial

Celyad Announces Registration of the first patient in the Belgian THINK trial ... Read more...

BICYCLE THERAPEUTICS APPOINTS NICHOLAS KEEN, PH.D., AS CHIEF SCIENTIFIC OFFICER
05 January 2017

BICYCLE THERAPEUTICS APPOINTS NICHOLAS KEEN, PH.D., AS CHIEF SCIENTIFIC OFFICER

BICYCLE THERAPEUTICS APPOINTS NICHOLAS KEEN, PH.D., AS CHIEF SCIENTIFIC OFFICER ... Read more...

Sphere Medical Holding plc - £3 Million Loan Facility
04 January 2017

Sphere Medical Holding plc - £3 Million Loan Facility

Sphere Medical Holding plc (“Sphere”, “Sphere Medical” or the “Company”) ... Read more...

Cambridge Innovation Capital leads Audio Analytic’s £4.3 million Series A funding round
04 January 2017

Cambridge Innovation Capital leads Audio Analytic’s £4.3 million Series A funding round

  Cambridge Innovation Capital leads Audio Analytic’s £4.3 million Series ... Read more...

MITHRA LAUNCHES ITS PRODUCT TIBELIA[1] ON THE GLOBAL MARKET
22 December 2016

MITHRA LAUNCHES ITS PRODUCT TIBELIA[1] ON THE GLOBAL MARKET

Mithra Pharmaceuticals received 14 Marketing Authorizations (MA) in 12 European countries for ... Read more...

Nexstim Plc pre-close business update
22 December 2016

Nexstim Plc pre-close business update

Nexstim Plc pre-close business update   ... Read more...

Nexstim Plc receives FDA’s response to the proposed limited size stroke trial plan
21 December 2016

Nexstim Plc receives FDA’s response to the proposed limited size stroke trial plan

Nexstim Plc receives FDA’s response to the proposed limited size stroke trial plan ... Read more...

Bone Therapeutics announces its financial calendar for 2017
21 December 2016

Bone Therapeutics announces its financial calendar for 2017

Press release                                                                                                    21 December 2016 Bone Therapeutics announces its financial calendar ... Read more...

Ogeda announces fezolinetant as INN and issuance of U.S. patent for ESN364
20 December 2016

Ogeda announces fezolinetant as INN and issuance of U.S. patent for ESN364

Ogeda announces fezolinetant as INN and issuance of U.S. patent for ESN364   ... Read more...

INNATE PHARMA ANNOUNCES KEY LEADERSHIP AND CORPORATE GOVERNANCE CHANGES TO SUPPORT NEXT STAGE OF DEVELOPMENT
19 December 2016

INNATE PHARMA ANNOUNCES KEY LEADERSHIP AND CORPORATE GOVERNANCE CHANGES TO SUPPORT NEXT STAGE OF DEVELOPMENT

INNATE PHARMA announces KEY leadership and Corporate governance changes to SUPPORT next stage of ... Read more...

MDxHealth Receives ISO 13485:2016 Certification for Dutch Laboratory
16 December 2016

MDxHealth Receives ISO 13485:2016 Certification for Dutch Laboratory

PRESS RELEASE                                                                               REGULATED INFORMATION INSIDE ... Read more...

Sphere Medical Holding plc - Appointment of Spanish Distributor
15 December 2016

Sphere Medical Holding plc - Appointment of Spanish Distributor

                                                                                                            15 December 2016   Sphere Medical Holding plc ... Read more...

Advanced Medical Solutions Group plc - Pre-Close Trading Update
15 December 2016

Advanced Medical Solutions Group plc - Pre-Close Trading Update

15 December 2016 Advanced Medical Solutions Group plc ("AMS" or the "Group") ... Read more...

Sphere Medical launches next generation analyser, Proxima 4
14 December 2016

Sphere Medical launches next generation analyser, Proxima 4

14 December 2016   Sphere Medical Holding plc (“Sphere”, ... Read more...

Cambridge Medical Robotics Limited reveals Versius robotic surgery system
12 December 2016

Cambridge Medical Robotics Limited reveals Versius robotic surgery system

Cambridge Medical Robotics Limited ("CMR" or the "Company")   ... Read more...

Mithra Pharmaceuticals: SUCCESS FOR MYRING EUROPEAN CLINICAL TRIAL
08 December 2016

Mithra Pharmaceuticals: SUCCESS FOR MYRING EUROPEAN CLINICAL TRIAL

PRESS RELEASE success for Myring european clinical trial   ... Read more...

Nexstim Plc’s Financial Information in 2017
08 December 2016

Nexstim Plc’s Financial Information in 2017

Nexstim Plc’s Financial Information in 2017   ... Read more...

IBA’s Proteus®ONE approved in Japan
07 December 2016

IBA’s Proteus®ONE approved in Japan

  IBA’s Proteus ® ONE approved in Japan ... Read more...

Cambridge Innovation Capital appoints Dr Andrew Williamson as Investment Director
05 December 2016

Cambridge Innovation Capital appoints Dr Andrew Williamson as Investment Director

  Cambridge Innovation Capital appoints Dr Andrew Williamson as Investment ... Read more...

Horizon Discovery Group plc - Director/PDMR Shareholding
02 December 2016

Horizon Discovery Group plc - Director/PDMR Shareholding

Horizon Discovery Group plc    Director/PDMR Shareholding ... Read more...

Helsinn Integrative Care Announces 510(K) FDA Clearance for Medical Device Xonrid® Gel
01 December 2016

Helsinn Integrative Care Announces 510(K) FDA Clearance for Medical Device Xonrid® Gel

Helsinn Integrative Care Announces 510(K) FDA Clearance for Medical Device Xonrid ® ... Read more...

SUMMIT THERAPEUTICS WINS PRESTIGIOUS INDUSTRY AWARD
01 December 2016

SUMMIT THERAPEUTICS WINS PRESTIGIOUS INDUSTRY AWARD

Summit Therapeutics plc (“Summit” or “the Company”)   ... Read more...

Oxford BioMedica Announces a Strategic Alliance with Orchard Therapeutics
29 November 2016

Oxford BioMedica Announces a Strategic Alliance with Orchard Therapeutics

Oxford BioMedica Announces a Strategic Alliance with Orchard Therapeutics   ... Read more...

Nexstim Plc: The conversion of the convertible loan between Nexstim Plc and Bracknor
28 November 2016

Nexstim Plc: The conversion of the convertible loan between Nexstim Plc and Bracknor

The conversion of the convertible loan between Nexstim Plc and Bracknor ... Read more...

Nexstim Plc issues shares in standby equity distribution agreement pursuant to the financing arrangement announced on 21 July 2016